Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 289

Similar articles for PubMed (Select 10203281)

1.

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ.

J Natl Cancer Inst. 1999 Apr 7;91(7):620-5.

2.

Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.

Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, Stampfer MJ.

J Natl Cancer Inst. 2001 Sep 5;93(17):1330-6.

3.

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E.

J Natl Cancer Inst. 2000 Oct 4;92(19):1592-600.

4.

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, D├ęchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7.

5.

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X.

J Natl Cancer Inst. 1999 Jan 20;91(2):151-6.

6.

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):345-9.

7.

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E.

J Natl Cancer Inst. 2002 Jul 17;94(14):1099-106.

8.

Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.

Suzuki S, Kojima M, Tokudome S, Suzuki K, Ozasa K, Ito Y, Inaba Y, Tajima K, Nakachi K, Watanabe Y, Tamakoshi A; JACC Study Group.

Asian Pac J Cancer Prev. 2009 Dec;10 Suppl:45-9.

9.

Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.

Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Int J Cancer. 2007 May 1;120(9):2007-12.

PMID:
17266031
10.

Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study.

Wakai K, Ito Y, Suzuki K, Tamakoshi A, Seki N, Ando M, Ozasa K, Watanabe Y, Kondo T, Nishino Y, Ohno Y; JACC Study Group.

Jpn J Cancer Res. 2002 Dec;93(12):1279-86.

PMID:
12495466
11.
12.

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7.

13.

Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.

Teramukai S, Rohan T, Lee KY, Eguchi H, Oda T, Kono S.

Jpn J Cancer Res. 2002 Nov;93(11):1187-94.

PMID:
12460458
14.

Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.

Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1137-41.

15.

Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.

Vrieling A, Rookus MA, Kampman E, Bonfrer JM, Korse CM, van Doorn J, Lampe JW, Cats A, Witteman BJ, van Leeuwen FE, van't Veer LJ, Voskuil DW.

J Nutr. 2007 Feb;137(2):379-83.

16.

Insulin-like growth factor II and colorectal cancer risk in women.

Hunt KJ, Toniolo P, Akhmedkhanov A, Lukanova A, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):901-5.

17.

[Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].

Jiang B, Liu DB, Zhang X, DU LL, Han CZ.

Zhonghua Wei Chang Wai Ke Za Zhi. 2009 May;12(3):264-8. Chinese.

PMID:
19434535
18.

Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.

DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1444-51. Erratum in: Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1825.

19.

Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.

Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):763-8.

20.

Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.

Mikami K, Ozasa K, Nakao M, Miki T, Hayashi K, Watanabe Y, Mori M, Sakauchi F, Washio M, Kubo T, Suzuki K, Wakai K, Nakachi K, Tajima K, Ito Y, Inaba Y, Tamakoshi A; JACC Study Group.

Asian Pac J Cancer Prev. 2009 Dec;10 Suppl:57-61.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk